European Society of Gene & Cell Therapy Annual Congress 2025

As a global leader in quality, compliance, and safety services, our attendance reflects our continued commitment to supporting the advancement of gene and cell therapies through proactive, science-driven pharmacovigilance. The ESGCT Congress brings together the foremost experts in genetic and cellular innovation, offering a critical platform to engage with evolving scientific developments, emerging safety considerations, and regulatory expectations in this rapidly progressing field.

Radiofilum Pharmaceutical ’s presence at this event highlights our dedication to staying at the forefront of advanced therapeutic technologies. By connecting with researchers, industry leaders, and regulatory authorities, we aim to deepen our understanding of the unique safety profiles associated with gene and cell therapies and ensure our clients are equipped with the strategic insight and compliance support needed to navigate this complex landscape. We look forward to bringing these insights back to our global partners to help advance safe, effective, and compliant therapeutic solutions for patients worldwide.

Exhibiting: Booth #C16

Attendees:

• Jamie Logan
• Simona Guidi
• Vinicus Beal Boufleur
• Rhydian Howells
• Paula van Hennik